MercadanteS: Stop and go strategy for opioid switching requires flexibility. Eur J Cancer, 2012; 48:944–945; author reply 946–947.
2.
RipamontiC, GroffL, BrunelliC, et al.: Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio?. J Clin Oncol, 1998; 16:3216–3221.
3.
BrueraE, PereiraJ, WatanabeS, et al.: Opioid rotation in patients with cancer pain: A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine. Cancer, 1996; 78:852–857.
4.
HernansanzS, GutierrezC, Sanz-RubialesA, et al.: Opioid rotation to methadone at home. J Pain Symptom Manage, 2006; 31:2–4.
5.
ReddyA, SchulerUS, de la CruzM, et al.: Overall survival among cancer patients undergoing opioid rotation to methadone compared to other opioids. J Palliat Med, 2017; 20:656–661.
6.
TerpeningCM, JohnsonWM: Methadone as an analgesic: A review of the risks and benefits. W V Med J, 2007; 103:14–18.
7.
RipamontiC, DickersonED: Strategies for the treatment of cancer pain in the new millennium. Drugs, 2001; 61:955–977.
8.
ChochinovHM: Dignity in care: Time to take action. J Pain Symptom Manage, 2013; 46:756–759.
9.
BalaguerA, Monforte-RoyoC, Porta-SalesJ, et al.: An international consensus definition of the wish to hasten death and its related factors. PLoS One, 2016; 11:e0146184.
10.
Rehmann-SutterC, GudatH, OhnsorgeK: The Patient's Wish to Die: Research, Ethics, and Palliative Care. Oxford: Oxford University Press, 2015, p. 264.